Predicting checkpoint inhibitor-associated autoimmune diabetes: prospects and limitations.
Saved in:
| Title: | Predicting checkpoint inhibitor-associated autoimmune diabetes: prospects and limitations. |
|---|---|
| Authors: | Herold KC; Department of Internal Medicine, and.; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, USA., Perdigoto AL; Department of Internal Medicine, and.; Veterans Administration Hospital, West Haven, Connecticut, USA. |
| Source: | The Journal of clinical investigation [J Clin Invest] 2026 Feb 16; Vol. 136 (4). Date of Electronic Publication: 2026 Feb 16 (Print Publication: 2026). |
| Publication Type: | Journal Article; Comment |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: eCollection Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1558-8238 |
|---|---|
| DOI: | 10.1172/JCI202477 |
